DK2431360T3 - Derivater af dihydrobenzoxathiazepiner, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse, såvel som deres anvendelse som modulatorer af AMPA-receptorer - Google Patents
Derivater af dihydrobenzoxathiazepiner, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse, såvel som deres anvendelse som modulatorer af AMPA-receptorerInfo
- Publication number
- DK2431360T3 DK2431360T3 DK11290413.1T DK11290413T DK2431360T3 DK 2431360 T3 DK2431360 T3 DK 2431360T3 DK 11290413 T DK11290413 T DK 11290413T DK 2431360 T3 DK2431360 T3 DK 2431360T3
- Authority
- DK
- Denmark
- Prior art keywords
- dihydrobenzoxathiazepines
- modulators
- derivatives
- processes
- preparation
- Prior art date
Links
- 102000003678 AMPA Receptors Human genes 0.000 title 1
- 108090000078 AMPA Receptors Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
- C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1003683A FR2964969B1 (fr) | 2010-09-16 | 2010-09-16 | Nouveaux derives dihydrobenzoxathiazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2431360T3 true DK2431360T3 (da) | 2013-07-22 |
Family
ID=43067253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK11290413.1T DK2431360T3 (da) | 2010-09-16 | 2011-09-15 | Derivater af dihydrobenzoxathiazepiner, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse, såvel som deres anvendelse som modulatorer af AMPA-receptorer |
Country Status (40)
Country | Link |
---|---|
US (1) | US8569285B2 (da) |
EP (1) | EP2431360B1 (da) |
JP (1) | JP2013537216A (da) |
KR (1) | KR20130054438A (da) |
CN (1) | CN103153973A (da) |
AP (1) | AP2013006793A0 (da) |
AR (1) | AR082973A1 (da) |
AU (1) | AU2011213898A1 (da) |
BR (1) | BR112013005967A2 (da) |
CA (1) | CA2752131C (da) |
CL (1) | CL2013000655A1 (da) |
CO (1) | CO6680709A2 (da) |
CR (1) | CR20130105A (da) |
CU (1) | CU20130037A7 (da) |
CY (1) | CY1114110T1 (da) |
DK (1) | DK2431360T3 (da) |
EA (1) | EA201300340A1 (da) |
EC (1) | ECSP13012489A (da) |
ES (1) | ES2421504T3 (da) |
FR (1) | FR2964969B1 (da) |
GE (1) | GEP20156247B (da) |
GT (1) | GT201300067A (da) |
HR (1) | HRP20130505T1 (da) |
IL (1) | IL225209A0 (da) |
MA (1) | MA34529B1 (da) |
ME (1) | ME01524B (da) |
MX (1) | MX2013002892A (da) |
NI (1) | NI201300028A (da) |
PE (1) | PE20131342A1 (da) |
PL (1) | PL2431360T3 (da) |
PT (1) | PT2431360E (da) |
RS (1) | RS52835B (da) |
SA (1) | SA111320755B1 (da) |
SG (1) | SG188380A1 (da) |
SI (1) | SI2431360T1 (da) |
TW (1) | TWI421080B (da) |
UA (1) | UA105320C2 (da) |
UY (1) | UY33574A (da) |
WO (1) | WO2012035216A1 (da) |
ZA (1) | ZA201106353B (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111518058B (zh) * | 2020-05-29 | 2021-03-09 | 四川大学华西医院 | 一种噁噻嗪类化合物及其用途 |
CN111559990B (zh) * | 2020-05-29 | 2021-03-09 | 四川大学华西医院 | 一种小分子噁噻嗪类衍生物及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0101280A3 (en) * | 1998-02-18 | 2003-02-28 | Neurosearch As | Positive ampa receptor modulator compounds and their use |
TWI232863B (en) * | 2001-06-11 | 2005-05-21 | Akzo Nobel Nv | Benzoxazepine derivatives |
CN101029051B (zh) * | 2001-06-14 | 2010-06-09 | 欧加农股份有限公司 | 作为AMPA受体正性调节剂的(噻吩并)-[f]-氧杂吖庚因-5-酮衍生物 |
FR2856064B1 (fr) * | 2003-06-13 | 2005-08-19 | Servier Lab | Nouveaux derives de benzothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
-
2010
- 2010-09-16 FR FR1003683A patent/FR2964969B1/fr not_active Expired - Fee Related
-
2011
- 2011-08-24 UY UY0001033574A patent/UY33574A/es unknown
- 2011-08-25 AU AU2011213898A patent/AU2011213898A1/en not_active Abandoned
- 2011-08-30 ZA ZA2011/06353A patent/ZA201106353B/en unknown
- 2011-09-07 CA CA2752131A patent/CA2752131C/fr not_active Expired - Fee Related
- 2011-09-07 TW TW100132314A patent/TWI421080B/zh not_active IP Right Cessation
- 2011-09-14 SA SA111320755A patent/SA111320755B1/ar unknown
- 2011-09-14 AR ARP110103332A patent/AR082973A1/es unknown
- 2011-09-15 ME MEP-2013-82A patent/ME01524B/me unknown
- 2011-09-15 MA MA35744A patent/MA34529B1/fr unknown
- 2011-09-15 BR BR112013005967A patent/BR112013005967A2/pt not_active Application Discontinuation
- 2011-09-15 RS RS20130274A patent/RS52835B/en unknown
- 2011-09-15 KR KR1020137009580A patent/KR20130054438A/ko not_active Application Discontinuation
- 2011-09-15 CN CN2011800437978A patent/CN103153973A/zh active Pending
- 2011-09-15 GE GEAP201113048A patent/GEP20156247B/en unknown
- 2011-09-15 SG SG2013015904A patent/SG188380A1/en unknown
- 2011-09-15 EA EA201300340A patent/EA201300340A1/ru unknown
- 2011-09-15 MX MX2013002892A patent/MX2013002892A/es active IP Right Grant
- 2011-09-15 PE PE2013000377A patent/PE20131342A1/es not_active Application Discontinuation
- 2011-09-15 SI SI201130030T patent/SI2431360T1/sl unknown
- 2011-09-15 ES ES11290413T patent/ES2421504T3/es active Active
- 2011-09-15 PL PL11290413T patent/PL2431360T3/pl unknown
- 2011-09-15 PT PT112904131T patent/PT2431360E/pt unknown
- 2011-09-15 JP JP2013528735A patent/JP2013537216A/ja active Pending
- 2011-09-15 WO PCT/FR2011/000502 patent/WO2012035216A1/fr active Application Filing
- 2011-09-15 UA UAA201304534A patent/UA105320C2/ru unknown
- 2011-09-15 US US13/200,045 patent/US8569285B2/en not_active Expired - Fee Related
- 2011-09-15 EP EP11290413.1A patent/EP2431360B1/fr active Active
- 2011-09-15 AP AP2013006793A patent/AP2013006793A0/xx unknown
- 2011-09-15 DK DK11290413.1T patent/DK2431360T3/da active
-
2013
- 2013-03-08 CL CL2013000655A patent/CL2013000655A1/es unknown
- 2013-03-11 CR CR20130105A patent/CR20130105A/es unknown
- 2013-03-12 CO CO13049160A patent/CO6680709A2/es not_active Application Discontinuation
- 2013-03-14 CU CU2013000037A patent/CU20130037A7/es unknown
- 2013-03-14 IL IL225209A patent/IL225209A0/en unknown
- 2013-03-14 GT GT201300067A patent/GT201300067A/es unknown
- 2013-03-14 NI NI201300028A patent/NI201300028A/es unknown
- 2013-03-15 EC ECSP13012489 patent/ECSP13012489A/es unknown
- 2013-06-07 HR HRP20130505AT patent/HRP20130505T1/hr unknown
- 2013-07-03 CY CY20131100553T patent/CY1114110T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3192500T3 (da) | Sammensætninger til kontinuerlig indgivelse af dopa-decarboxylasehæmmere | |
DK2603513T3 (da) | Heterocyklisk forbindelse og anvendelse deraf som AMPA-receptorpositiv allosterisk modulator | |
DK3124483T3 (da) | Pyrazolaminopyrimidin-derivater som LRRK2-modulatorer | |
DK3632919T3 (da) | Farmaceutiske sammensætninger omfattende imidazothiadiazol- og imidazopyrazinderivater som proteaseaktiverede receptor 4-(par4)- hæmmere til behandling af blodpladeaggregering | |
DK2411397T3 (da) | Isothiazol-pyrimidindionderivater som modulatorer af TRPA1 | |
BR112014013760A2 (pt) | composto, composição farmacêutica e uso de um composto | |
BR112014001255A2 (pt) | composto, uso de um composto, combinação, e, composição farmacêutica | |
DK2751102T3 (da) | Forbindelser og sammensætninger som C-kit-kinasehæmmere | |
BR112014007134A2 (pt) | usos de um composto da fórmula (b), compostos, composição farmacêutica, método de preparação do composto e uso de uma quantidade efetiva de um composto | |
BR112014029530A2 (pt) | compostos, composição farmacêutica e uso de um composto | |
DK2542535T3 (da) | Krystalformer af 5-amino-2,3-dihydrophthalazin-1,4-dion-natriumsalt, farmaceutiske præparater indeholdende disse samt fremgangsmåder til deres fremstilling | |
BR112014005669A2 (pt) | composto, composição farmacêutica e uso de um composto | |
BR112013015397A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BR112014003567A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
CO7020907A2 (es) | Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos | |
BR112015007310A2 (pt) | compostos, composição farmacêutica, uso de um composto de fórmula (i) e uso de uma composição farmacêutica | |
DK2408446T3 (da) | Anvendelse af farmaceutiske sammensætninger, der indeholder mesembrenon | |
BR112014013177A2 (pt) | composto, composição farmacêutica e uso de um composto | |
DK2405972T3 (da) | Anvendelse af rosuvastatin lactoler som medikamenter | |
DK2658851T3 (da) | Heterocykliske forbindelser, som er egnede til behandling af dyslipidæmi | |
BR112014013178A2 (pt) | composto, composição farmacêutica e uso de um composto | |
HK1191330A1 (en) | Ethynyl derivatives as positive allosteric modulators of the mglur5 mglur5 | |
DK2281822T3 (da) | Nye dihydroindolonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse | |
DK2817299T3 (da) | Substituerede chromanforbindelser som modulatorer af calciumdetekterende receptorer | |
DK2606042T3 (da) | Disubstituerede tetrahydrofuranyl-forbindelser som antagonister af bradykinin-b1-receptor |